STEPHEN PFLUGFELDER to Visual Acuity
This is a "connection" page, showing publications STEPHEN PFLUGFELDER has written about Visual Acuity.
Connection Strength
1.746
-
The impact of the Boston ocular surface prosthesis on wavefront higher-order aberrations. Am J Ophthalmol. 2011 Apr; 151(4):682-690.e2.
Score: 0.268
-
Addressing corneal opacity after herpes zoster infection. J Cataract Refract Surg. 2024 Jun 01; 50(6):655-659.
Score: 0.169
-
Conjunctivochalasis and Tear Osmolarity Are Associated With Reduced Conjunctival Epithelial Thickness in Dry Eye. Am J Ophthalmol. 2021 07; 227:35-44.
Score: 0.134
-
Topical Recombinant Human Nerve Growth Factor (Cenegermin) for Neurotrophic Keratopathy: A Multicenter Randomized Vehicle-Controlled Pivotal Trial. Ophthalmology. 2020 01; 127(1):14-26.
Score: 0.122
-
Bilateral Candida parapsilosis infiltration of nonhealing indolent epithelial defects in a diabetic patient with neurotrophic keratopathy. Can J Ophthalmol. 2018 12; 53(6):e224-e226.
Score: 0.110
-
Assessment of the Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) scleral lens on visual acuity for corneal irregularity and ocular surface disease. Ocul Surf. 2018 04; 16(2):254-258.
Score: 0.109
-
Patient ocular conditions and clinical outcomes using a PROSE scleral device. Cont Lens Anterior Eye. 2013 Aug; 36(4):159-63.
Score: 0.078
-
PROSE therapy used to minimize corneal trauma in patients with corneal epithelial defects. Am J Ophthalmol. 2013 Apr; 155(4):615-619, 619.e1-2.
Score: 0.076
-
The successful use of Boston ocular surface prosthesis in the treatment of persistent corneal epithelial defect after herpes zoster ophthalmicus. Cornea. 2010 Dec; 29(12):1465-8.
Score: 0.066
-
Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest Ophthalmol Vis Sci. 2009 Jul; 50(7):3203-9.
Score: 0.059
-
Therapy of progressive rheumatoid arthritis-associated corneal ulceration with infliximab. Cornea. 2005 Aug; 24(6):742-4.
Score: 0.046
-
A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol. 2004 Sep; 138(3):444-57.
Score: 0.043
-
Assessing the severity of keratitis sicca with videokeratoscopic indices. Ophthalmology. 2003 Jun; 110(6):1102-9.
Score: 0.039
-
Keratoconus-like topographic changes in keratoconjunctivitis sicca. Cornea. 2003 Jan; 22(1):22-4.
Score: 0.038
-
Pseudokeratoconus caused by rosacea. Cornea. 2001 Aug; 20(6):668-9.
Score: 0.035
-
Effects of laser in situ keratomileusis on tear production, clearance, and the ocular surface. Ophthalmology. 2001 Jul; 108(7):1230-5.
Score: 0.035
-
The effects of experimental tear film removal on corneal surface regularity and barrier function. Ophthalmology. 2000 Sep; 107(9):1754-60.
Score: 0.033
-
[The effect of artificial tears on corneal surface regularity in dry eye]. Zhonghua Yan Ke Za Zhi. 2000 Mar; 36(2):131-4.
Score: 0.031
-
The effects of long-term contact lens wear on corneal thickness, curvature, and surface regularity. Ophthalmology. 2000 Jan; 107(1):105-11.
Score: 0.031
-
Corneal surface regularity and the effect of artificial tears in aqueous tear deficiency. Ophthalmology. 1999 May; 106(5):939-43.
Score: 0.030
-
Conjunctival intraepithelial neoplasia. A possible marker for human immunodeficiency virus infection? Arch Ophthalmol. 1996 Mar; 114(3):257-61.
Score: 0.024
-
Effect of loteprednol etabonate 0.5% on initiation of dry eye treatment with topical cyclosporine 0.05%. Eye Contact Lens. 2014 Sep; 40(5):289-96.
Score: 0.022
-
Endophthalmitis caused by Staphylococcus aureus. Am J Ophthalmol. 1993 Nov 15; 116(5):584-9.
Score: 0.020
-
Long-term Supplementation With n-6 and n-3 PUFAs Improves Moderate-to-Severe Keratoconjunctivitis Sicca: A Randomized Double-Blind Clinical Trial. Cornea. 2013 Oct; 32(10):1297-304.
Score: 0.020
-
Endophthalmitis caused by gram-negative organisms. Arch Ophthalmol. 1992 Oct; 110(10):1450-4.
Score: 0.019
-
Epstein-Barr virus keratitis after a chemical facial peel. Am J Ophthalmol. 1990 Nov 15; 110(5):571-3.
Score: 0.017
-
Bilateral acanthamoeba keratitis. Am J Ophthalmol. 2008 Feb; 145(2):193-197.
Score: 0.014
-
Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years. Ophthalmology. 2005 Oct; 112(10):1790-4.
Score: 0.012
-
Recurrent fungal keratitis and endophthalmitis. Cornea. 2000 Jul; 19(4):558-60.
Score: 0.008
-
Endophthalmitis associated with microbial keratitis. Ophthalmology. 1996 Nov; 103(11):1864-70.
Score: 0.006
-
Capnocytophaga endophthalmitis. Ophthalmology. 1993 Apr; 100(4):456-9.
Score: 0.005
-
Paracentral rheumatoid corneal ulceration. Clinical features and cyclosporine therapy. Ophthalmology. 1992 Jan; 99(1):80-8.
Score: 0.004
-
Delayed-onset pseudophakic endophthalmitis. Am J Ophthalmol. 1991 Feb 15; 111(2):163-73.
Score: 0.004
-
Penetrating ocular injury from contaminated eating utensils. Arch Ophthalmol. 1991 Jan; 109(1):63-6.
Score: 0.004
-
Endogenous Candida endophthalmitis. Management without intravenous amphotericin B. Ophthalmology. 1990 May; 97(5):666-72; disc: 672-4.
Score: 0.004
-
Granular epithelial keratopathy as an unusual manifestation of Pseudomonas keratitis associated with extended-wear soft contact lenses. Am J Ophthalmol. 1990 Jan 15; 109(1):17-22.
Score: 0.004
-
Mycobacterium tuberculosis scleritis. Am J Ophthalmol. 1989 Dec 15; 108(6):736-7.
Score: 0.004
-
Management options for Propionibacterium acnes endophthalmitis. Ophthalmology. 1989 Jul; 96(7):1100-5.
Score: 0.004